BS
Therapeutic Areas
Renibus Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Veverimer (TRC101) | Chronic Kidney Disease with Metabolic Acidosis | Phase 3 |
| Veverimer | Anti-glomerular Basement Membrane Disease (anti-GBM) | Orphan Designated |
| RBT-1 | Reduce post-op complications in cardiac surgery (higher-risk patients) | Phase 3 |